Nagi Bioscience launches exclusive Priority Access Program, bringing revolutionary SydLab™ One platform to five leading academic labs for C. elegans research

Nagi Bioscience, a pioneer Swiss company pioneer in cutting-edge laboratory technologies for alternative model organisms research, proudly announces the launch of its exclusive Priority Access Program, providing access to five leading academic laboratories to the first-of-its-kind SydLab One platform. With a focus on research applications in oncology, neurodegenerative diseases, aging and age-related conditions, and toxicology, SydLab One is set to facilitate and accelerate the ground-breaking research projects of the five participating laboratories.

Starting the installations in September 2024, SydLab One will be used in each of the participants facilities where it will enable researchers to conduct high-throughput and precise experiments with unprecedented efficiency, reliability, and reproducibility during a six-months period.

We are thrilled and honored to see our technology being adopted in an increasing number of research projects and centers, including some of the most prestigious laboratories in the world.”

Matteo Cornaglia, PhD, CEO and co-founder, Nagi Bioscience

“The SydLab platform is the culmination of over 10 years of multidisciplinary research and development, and it is truly fascinating to now witness its transformative potential in accelerating scientific discoveries in critical medical fields, such as neurodegenerative and age-related diseases, and beyond.”

The innovative SydLab One platform revolutionizes C. elegans experimentation, automating the entire process through a seamless integration of microfluidics, robotics, optics, and AI algorithms in just a single benchtop device. The five participating laboratories have been extensively recognized for their leadership in C. elegans research and in their respective application fields. They will be the first academic laboratories to integrate SydLabOne into their research facilities. Their feedback will be instrumental in refining the platform for broader applications, helping to shape the future of automated, standardized and alternative biological research, drug candidate discovery and safety assessment.

SydLab One represents a leap forward in experimental biology, designed to address the challenges faced by researchers working with C. elegans, a model organism widely used to understand biological processes and present in academic and industrial R&D laboratories for more than sixty years. With the launch of the Priory Access Program, Nagi Bioscience is ushering in a new era of automation in C. elegans research. By providing five leading academic labs with access to the revolutionary SydLab One platform, Nagi Bioscience empowers researchers to accelerate their work in critical fields such as oncology, neurodegenerative diseases, aging, and toxicology. This program marks a pivotal step in advancing biological research, enhancing efficiency, precision, and discovery potential across top institutions.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nagi Bioscience. (2024, September 20). Nagi Bioscience launches exclusive Priority Access Program, bringing revolutionary SydLab™ One platform to five leading academic labs for C. elegans research. News-Medical. Retrieved on October 11, 2024 from https://www.news-medical.net/news/20240920/Nagi-Bioscience-launches-exclusive-Priority-Access-Program-bringing-revolutionary-SydLabe284a2-One-platform-to-five-leading-academic-labs-for-C-elegans-research.aspx.

  • MLA

    Nagi Bioscience. "Nagi Bioscience launches exclusive Priority Access Program, bringing revolutionary SydLab™ One platform to five leading academic labs for C. elegans research". News-Medical. 11 October 2024. <https://www.news-medical.net/news/20240920/Nagi-Bioscience-launches-exclusive-Priority-Access-Program-bringing-revolutionary-SydLabe284a2-One-platform-to-five-leading-academic-labs-for-C-elegans-research.aspx>.

  • Chicago

    Nagi Bioscience. "Nagi Bioscience launches exclusive Priority Access Program, bringing revolutionary SydLab™ One platform to five leading academic labs for C. elegans research". News-Medical. https://www.news-medical.net/news/20240920/Nagi-Bioscience-launches-exclusive-Priority-Access-Program-bringing-revolutionary-SydLabe284a2-One-platform-to-five-leading-academic-labs-for-C-elegans-research.aspx. (accessed October 11, 2024).

  • Harvard

    Nagi Bioscience. 2024. Nagi Bioscience launches exclusive Priority Access Program, bringing revolutionary SydLab™ One platform to five leading academic labs for C. elegans research. News-Medical, viewed 11 October 2024, https://www.news-medical.net/news/20240920/Nagi-Bioscience-launches-exclusive-Priority-Access-Program-bringing-revolutionary-SydLabe284a2-One-platform-to-five-leading-academic-labs-for-C-elegans-research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.